Observational Study
Copyright ©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 90949
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.90949
Figure 1
Figure 1 Current hepatitis B immunoglobulin treatment. A: Life aspects affected; B: Patient experience. aP ≤ 0.05 denotes statistically significant difference vs intravenous hepatitis B immunoglobulin. 1Issues caused by treatment. HBIG: Hepatitis B immunoglobulin; IM: Intramuscular; IV: Intravenous; SC: Subcutaneous.